The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EU MONITOR – Last day to sign up for the Student Science Award webinar!
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
Students sign up for the EAHP-EPSA Student Science Award!
The next edition of the EAHP-EPSA Student Science Award will be kicked off tomorrow by the European Association of Hospital Pharmacists (EAHP). Hurry and register if you have not yet signed up for the webinar “How to write an abstract”, hosted by EAHP’s Directors of Professional Development Ana Lozano, Claudia Plesan and Piera Polidori.
The EAHP-EPSA Student Science Award recognises and honours the best scientific research authored by a pharmacy student or recent graduate. Since 2011 it is offered to one member of the European Pharmaceutical Students’ Association (EPSA) who has conducted research in the field of hospital and/or clinical pharmacy. To enter into the competition, students and recent graduates are required to attend tomorrow’s webinar “How to write an abstract”, taking place from 17.00 to 19.00 CET. Students and recent graduates can register by sending an email with their first and last name to intern@eahp.eu
After the webinar, participating students and recent graduates can obtain detailed feedback on their work prior to submitting their final abstract by 15th November. The abstracts are reviewed in accordance with the criteria of innovation, originality, and contribution to the development of hospital pharmacy. The author of the winning abstract will receive a complimentary registration to the 26th Congress of EAHP, including the coverage of travel and accommodation expenses (up to 500 Euros), as well as official recognition at the EAHP Congress closing ceremony on the 25th of March 2022.
More information about the EAHP-EPSA Student Science Award HERE
EDQM webinar – Resolution on good reconstitution practices
The European Directorate for the Quality of Medicines & HealthCare (EDQM) is organising a free webinar on 16 June 2021, from 10.30 AM to 12.00 PM CET, on the ‘Council of Europe Resolution on good reconstitution practices.’
This resolution was adopted by the Committee of Ministers of the Council of Europe in 2016, with a view to improving the safety of patients receiving reconstituted injectable medicines. The 90-minute, free webinar will provide some practical examples of how the provisions in the resolution can be transposed into national legislation and implemented in a hospital pharmacy setting. It will also help attendees learn how to overcome possible challenges affecting implementation.
The webinar is aimed at healthcare professionals, in particular, pharmacists working in hospital pharmacies, nurses and physicians, healthcare and patient associations, as well as national competent authorities and ministries of health.
Register for the webinar HERE
Learn more about the webinar on EDQM’s event web page HERE
Read the Resolution HERE
WHO – Antimicrobial stewardship interventions guide
The WHO Regional Office for Europe has made available a guide focusing on antimicrobial stewardship programmes which have been identified as one of the core strategies to tackle antimicrobial resistance (AMR). The guide addresses administrators, healthcare leaders and front-line clinicians, particularly in low-resource settings.
AMR is a global public health emergency, but selecting the most appropriate interventions for each setting remains challenging. The WHO’s practical guide describes 10 commonly used stewardship interventions, which promote the optimal use of antimicrobials at health care facilities. Users will learn about the most common interventions, the evidence behind them, as well as important implementation considerations, particularly for low-resource settings.
Access the guide HERE
Health Management: managing the present and shaping the future
The European Health Management Association is hosting its EHMA2021 Annual Conference under the theme ‘Health Management: managing the present and shaping the future’ on 15-17 September 2021 in Lisbon, Portugal.
The EHMA Annual Conference is the place for all healthcare stakeholders to come together, discuss current topics and exchange innovation and best practices. EHMA strives to gather and connect the full healthcare ecosystem of academia, educators, research, health and hospital managers, healthcare professionals, students, policy- and decision-makers from Europe and beyond. At EHMA 2021 you will be discussing ‘Health Management: managing the Present and preparing for the Future’ through key themes that are the pillars of a successful response to the current and future needs of health management.
Find more information HERE
EJHP: Therapeutic drug monitoring of voriconazole: validation of a high performance liquid chromatography method and comparison with an ARK immunoassay
The original research published in the online edition of the European Journal of Hospital Pharmacy (EJHP) studies the development and validation of a high performance liquid chromatography (HPLC) method for measuring voriconazole in human serum, and comparison with an ARK immunoassay method. The method was applied to the analysis of 58 trough serum samples from patients treated with voriconazole, and the HPLC-UV (ultraviolet) method was compared with an ARK immunoassay. The correlation of both methods was studied by the Pearson regression coefficient and the concordance of the values was evaluated by the Bland-Altman and Passing-Bablok methods. These results show that the method developed is simple and fast and can be easily applied for routine therapeutic drug monitoring of voriconazole. The HPLC-UV method was more sensitive than the immunoassay method and there was concordance with the immunoassay. Consequently, both methods could be used, considering the correlation between them.
Read the article HERE
[COVID-19 Updates]
EAHP’s COVID-19 Resource Centre
To assist its member associations and individual hospital pharmacists in this critical time with the provision of the best possible care for patients, EAHP has decided to gather and make available information on COVID-19 relevant for the hospital pharmacy profession.
Access the Resource Centre HERE
Network of Scientific Medical Societies in Germany (AWMF) – Recommendations for inpatient therapy for patients with COVID-19 – Living Guideline| Empfehlungen zur stationären Therapie von Patienten mit COVID-19 – Living Guideline
AWMF has put together guideline on intensive care therapy for patients with COVID-19.
Read the guideline HERE
National Comprehensive Cancer Network – Management of COVID-19 Infection in Patients with Cancer
The guideline addresses indications for SARS-CoV-2 testing in patients with cancer, management of cancer-directed therapies during the COVID-19 pandemic, and therapy of COVID-19 infection in this patient group.
Read the guideline HERE
American Journal of Health-System Pharmacy – Providing essential clinical pharmacy services during a pandemic: Virtual video rounding and precepting
The research outlines the preparation for remote clinical services, the technology utilised, the perspectives of pharmacy preceptors and residents, and barriers encountered.
Read the article HERE
Clinical Microbiology and Infection – Intravenous immunoglobulin treatment for patients with severe COVID-19: a retrospective multi-center study
The study evaluated the effectiveness of Intravenous immunoglobulin (IVIG) treatment in severe COVID-19 patients.
Read the article HERE
Meet EAHP’s Statement Implementation Ambassadors
To promote the implementation of the European Statements of Hospital Pharmacy at national level EAHP has teamed up with motivated and enthusiastic hospital pharmacists willing to help their countries and others move towards Statement Implementation. The Implementation Ambassadors act as the primary link between EAHP, their national associations and the implementation activities done within their countries, convey to EAHP the needs and priorities of their countries and build resources that will help hospital pharmacists, healthcare professionals and other relevant stakeholders to implement the Statements within their hospitals. Get to know them here
___________________________________________________________________________________
Consultations
European Commission – Public Consultation: Digital health data and services – the European health data space
To ensure that all possible views are considered in the design of a legal framework for a European Health Data Space (EHDS), the European Commission invites all interested individuals and stakeholders to share their views and experiences. Your contribution can help provide important insights, opinions and evidence to support the impact assessment accompanying the EHDS proposal on the problems to be tackled, the policy options to be considered and their likely impacts.
Deadline – 26 July 2021
Access the consultation HERE
European Commission – Public Consultation: Cross-border healthcare – evaluation of patients’ rights
The Directive on patients’ rights in cross-border healthcare (2011/24/EU) aims to facilitate access to safe and high quality healthcare in another EU country. The European Commission invites all interested individuals and stakeholders to share their views and experience in seeking planned healthcare across the EU or in EU cooperation in the area of rare diseases.
Deadline – 27 July 2021
Access the consultation HERE
European Commission – Public Consultation: Medicines for children & rare diseases – updated rules
This initiative will explore several options to address the shortcomings identified in the evaluation of the Regulations on medicines for children and rare diseases, in view of a revision of the existing legislation. With this public consultation, citizens and stakeholders are invited to share their views and experiences on the main obstacles they are facing concerning treatments for rare diseases and children, on possible ways to overcome these obstacles and on how to make the current legislation future-proof.
Deadline – 30 July 2021
Access the consultation HERE